Bristol Myers Squibb (BMY) Stock Sinks As Market Gains: What You Should Know

Bristol Myers Squibb (BMY) Stock Sinks As Market Gains: What You Should Know
This story originally appeared on Zacks

In the latest trading session, Bristol Myers Squibb (BMY) closed at $61.45, marking a -0.44% move from the previous day. This change lagged the S&P 500’s daily gain of 1.78%. Meanwhile, the Dow gained 1.61%, and the Nasdaq, a tech-heavy index, added 0.95%.

Bristol Myers Squibb (BMY) Stock Sinks As Market Gains: What You Should Know – Zacks

Heading into today, shares of the biopharmaceutical company had gained 8.2% over the past month, outpacing the Medical sector’s loss of 0.46% and the S&P 500’s loss of 2.63% in that time.

Wall Street will be looking for positivity from Bristol Myers Squibb as it approaches its next earnings report date. This is expected to be February 4, 2022. On that day, Bristol Myers Squibb is projected to report earnings of $1.85 per share, which would represent year-over-year growth of 26.71%. Our most recent consensus estimate is calling for quarterly revenue…

Continue reading